07/10/2020 - Institutional, Research

A new paper shows how the CMCiB will shine a new light on neurobiology

A review paper with first author Marc Melià-Sorolla of the Cellular and Molecular Neurobiology Research Group and published in the International Journal of Molecular Sciences highlights a porcine model as the most suitable for stroke research in the future. The CMCiB-IGTP is equipped to carry out this type of research and the group led by Teresa Gasull are already showing the potential of the non-invasive bioimaging technology.

06/10/2020 - Research

Fifty professionals were on-site for the XVIII Workshop on Translational Research in Digestive Neoplasms

On 1-2 October the 18th edition of the Workshop on Translational Research in Digestive Neoplasms took place, organized by the IGTP and the Catalan Institute of Oncology (ICO). This edition was inevitably marked by all the safety measures required due to the pandemic, but it also provided a programme that did not disappoint those attending.

02/10/2020 - Research

Will curcumin be a valid therapy for colorectal cancer? Getting to the facts

A new paper reviews the use of curcumin, the active ingredient in turmeric, as a possible combination with current therapies for colorectal cancer, it has been published in Seminars in Cancer Biology. The study, led by Vicenç Ruiz de Porras of the IGTP and ICO shows that research so far points to curcumin being a likely candidate for future cancer therapies.

29/09/2020 - Campus Can Ruti, Institutional

Jordi Barretina, the new Director of the Germans Trias i Pujol Research Institute

Jordi Barretina Ginesta is the new Director of the Germans Trias i Pujol Research Institute (IGTP) on Campus Can Ruti, Badalona; he will take up the role this October. The open selection process was managed by the CERCA institution, of which the IGTP is a member. Dr Barretina will take over from Dr Manel Puig Domingo, who is stepping down as director of the research centre after seven years in the post.

18/09/2020 - Research

New community strategies to promote Health and screening for the micro-elimination of hepatitis C in migrants

The project is a pilot programme for the implementation and validation of the micro-elimination of Hepatitis C based on a community strategy. The validation has focussed on a migrant Pakistani population in Barcelona and the metropolitan area and is now being extended to migrants from other countries where the disease is endemic and to screening for Hepatitis B. The study unites two previously validated strategies to bring education about hepatitis (VHIR) and diagnostics (IGTP) to these vulnerable populations in the community.

08/09/2020 - Research

The CMCiB, ready for advanced research on SARS-CoV-2

The Centre for Comparative medicine and Bioimage (CMCiB) of the IGTP has its level 3 biological containment laboratories (BCLL3) ready to receive new projects related to the study of the SARS-CoV-2 virus. These facilities are biological containment areas designed for work on microorganisms that cause infectious diseases, especially those with a high risk of transmission through the diffusion of aerosols.

03/09/2020 - Institutional

Julia Garcia-Prado selected for the EATRIS Scientific Committee in Spain

Dr Julia Garcia Prado, Scientific Director of the IGTP and Leader of the VIRIEVAC Group at IrsiCaixa, has been appointed member of the new EATRIS Scientific Committee for Spain. The new body is part of the strategic plan of action for the EATRIS Spain node to increase its presence in the network and increase strategic international collaborations between biomedical research institutes.

21/08/2020 - Research

Plasmodium vivax parasites are shown to be present and causing changes in bone marrow during Malaria Infections

Three groups from the IGTP have collaborated on a study of the parasite Plasmodium vivax with several Brazilian groups. The paper published in the Journal of Infectious Diseases provides proof of the presence of P. vivax in bone marrow during infections, something which has been controversial until now. They also showed that it disrupts normal red blood cell production, as well as altering the immune response.

05/08/2020 - Amics deCan Ruti, Research

Employees of Innospec are adding their grain of sand to research into the treatment for Friedreich’s ataxia

The staff of the company Innospec have donated their Silver Corporate Safety Award to the research effort to find a treatment for Friedreich's ataxia, a project led by Dr Antonio Matilla and Dr Ivelisse Sánchez of the Neurogenetics Group at the IGTP.

05/08/2020 - Projects, Research

Full marks for the mid-term meeting of the European Project INNOVA4TB coordinated from the IGTP

At the start of Julio the mid-tem meeting of the European project "Innovation in Tuberculosis-INNOVA4TB", designed and coordinated by the Innovation in Respiratory Infections and Tuberculosis Diagnosis research group led by Dr José Dominguez and Cristina Prat took place. INNOVA4TB is a European Project focused on the diagnosis and clinical handling of tuberculosis financed by a Marie Skłodowska Curie award.